Which are the top companies hold the market share in Influenza Vaccine Market?

Sanofi S.A., AstraZeneca plc, CSL Limited, BIKEN Co, Ltd., GlaxoSmithKline plc, Abbott, Sinovac Biotech Ltd., Viatris Inc., Merck & Co, Inc., EMERGEX VACCINES, Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, Novavax, Inc., F. Hoffmann –La Roche Ltd, Baxter International Inc., Flugen Inc., Vaxart Inc., Altimmune Inc., Shijiazhuang Yiling Pharmaceutical Co, Ltd, BiondVax Pharmaceuticals Ltd., Daiichi Sankyo Company, Other Key Players

What is the projected market size & growth rate of the Influenza Vaccine Market?

Influenza Vaccine Market size is expected to be worth around USD 6.2 Billion by 2022 from USD 12.6 Billion in 2032

What are the key driving factors for the growth of the Influenza Vaccine Market?

The significant increase within the government initiatives promoting the administration of influenza vaccine, minimal side effects related to the vaccine contributes to the expansion of the Influenza Vaccine Market.

Influenza Vaccine Market Size, Share, Growth

Global Influenza Vaccine Market By Type (Live Attenuated and Inactivated), By Age Group (Pediatrics and Adults), By Distribution Channel (Hospital Pharmacy & Retail Pharmacy, Government Suppliers, Other Distribution Channels), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

- Get a FREE Sample -

Our Clients